
SCellex is a Finnish biotech company specializing in advanced spatial transcriptomics technology for single-cell gene expression analysis. Their patent-pending visual barcoding technology uses colored feature barcode beads in high-throughput picowell arrays to enable RNA capture from tissue sections or single-cell suspensions. This technology supports high-resolution, scalable solutions for accelerating diagnostics, drug discovery, and personalized therapies, with a strong focus on cancer research. SCellex's platform integrates AI analysis and offers versatile applications including multi-omics and functional assays, positioning the company as an innovative player in life sciences research tools.

SCellex is a Finnish biotech company specializing in advanced spatial transcriptomics technology for single-cell gene expression analysis. Their patent-pending visual barcoding technology uses colored feature barcode beads in high-throughput picowell arrays to enable RNA capture from tissue sections or single-cell suspensions. This technology supports high-resolution, scalable solutions for accelerating diagnostics, drug discovery, and personalized therapies, with a strong focus on cancer research. SCellex's platform integrates AI analysis and offers versatile applications including multi-omics and functional assays, positioning the company as an innovative player in life sciences research tools.